B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients

Clinical Nephrology

Volumn 76, Issue 5, 2011, Pages 373-379

  Westenbrink, B D ^a   Hovinga, T K Kremer ^a   Kloppenburg, W D ^a   Veeger, N J ^b   Janssen, W M T ^a  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

BNP; Dialysis; Fluid retention; Mortality

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIALYSIS FLUID;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIALYSATE; DIURESIS; FEMALE; FLUID RETENTION; HEART FUNCTION; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SURVIVAL; WEIGHT GAIN;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPOVOLEMIA; KIDNEY FAILURE, CHRONIC; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 82155167195     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106858     Document Type: Article

References (16)

1. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009; 119: 671-679.
2. Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol. 2004; 93: 1254-1259.
3. Stegmayr BG. Ultrafiltration and dry weight-what are the cardiovascular effects? Artif Organs. 2003; 27: 227-229.
4. London GM, Marchais SJ, Metivier F, Guerin AP. Cardiovascular risk in end-stage renal disease: vascular aspects. Nephrol Dial Transplant. 2000; 15 (Suppl 5): 97-104.
5. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006; 26: 118-133.
6. Weinreich T, De los Ríos T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol. 2006; 66: 433-439.
7. Hörl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med. 2005; 53: 366-370.
8. Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int. 2005; 68: 854-861.
9. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis. 2003; 41: 1267-1277.
10. O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010; 7: 13-20.
11. López-Gómez JM, Villaverde M, Jofre R, Rodriguez-Benítez P, Pérez-García R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int. 2005; 67 (Suppl 93): S63-S68.
12. Bednarek-Skublewska A, Zaluska W, Ksiazek A. The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients. Clin Nephrol. 2010; 73: 14-20.
13. Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH. NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol. 2009; 71: 380-386.
14. Kayatas M, Ozdemir N, Muderrisoglu H, Ulucam M, Turan M, Hizel N. Comparison of the non-invasive methods estimating dry weight in hemodialysis patients. Ren Fail. 2006; 28: 217-222.
15. Roueff S, Martin E, Chauffert ML, Poli I, Kihal K, Yazbeck F, Abbassi A, Saint-Georges M. Brain natriuretic peptide variations are linked to volume status in hemodialysis patients. Clin Nephrol. 2008; 70: 508-513.
16. Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D. NTproBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010; 25: 551-557.